Alopecia

Posts

Men and Women Hair Loss Market

Men and Women Hair Loss Market

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Men and Women Hair Loss market report provide a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Men and Women Hair Loss size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Men and Women Hair Loss market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

The men and Women Hair Loss market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Market segment by Application can be divided into

Men

Women

Market segment by players, this report covers

Procter & Gamble

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer Inc.

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs Ltd.

Ultrax Labs

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of the Middle East & Africa)

The content of the study subjects includes a total of 12 chapters:

Chapter 1, describe Men and Women Hair Loss product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, profile the top players of Men and Women Hair Loss, with revenue, gross margin and global market share of Men and Women Hair Loss from 2019 to 2021.

Chapter 3, the Men and Women Hair Loss competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021. and Men and Women Hair Loss market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, describe Men and Women Hair Loss research findings and conclusion, appendix and data source.

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Source

Recent Posts

Men and Women Hair Loss Market

Men and Women Hair Loss Market

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

The Men and Women Hair Loss market report provide a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Men and Women Hair Loss size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Men and Women Hair Loss market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation

The men and Women Hair Loss market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers

Hair Loss and Growth Devices

Shampoos and Conditioners

Medicine Product

Market segment by Application can be divided into

Men

Women

Market segment by players, this report covers

Procter & Gamble

L’Oreal

Unilever

Taisho

Henkel

Merck

Shiseido

Johnson & Johnson Consumer Inc.

Rohto

Lifes2Good

Gerolymatos International

Toppik

Nanogen

Oxford BioLabs Ltd.

Ultrax Labs

Market segment by regions, regional analysis covers

North America (United States, Canada, and Mexico)

Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)

South America (Brazil, Argentina, Rest of South America)

Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of the Middle East & Africa)

The content of the study subjects includes a total of 12 chapters:

Chapter 1, describe Men and Women Hair Loss product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, profile the top players of Men and Women Hair Loss, with revenue, gross margin and global market share of Men and Women Hair Loss from 2019 to 2021.

Chapter 3, the Men and Women Hair Loss competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.

Chapter 6, 7, 8, 9, and 10, break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021. and Men and Women Hair Loss market forecast, by regions, type and application, with revenue, from 2021 to 2026.

Chapter 11 and 12, describe Men and Women Hair Loss research findings and conclusion, appendix and data source.

Global Men and Women Hair Loss Market 2021 by Company, Regions, Type and Application, Forecast to 2026

Source

Recent Posts

Global Alopecia (Hair Loss Treatment) Market

Global Alopecia Market

Global Alopecia (Hair Loss Treatment) Market

Industry Growth Insights published new data on the “Alopecia (Hair Loss Treatment) Market”. The research report is titled “Alopecia (Hair Loss Treatment) Market research by Types (Shampoos and Conditioners, Medicine Product), By Applications (Men, Women), By Players/Companies Shiseido, Rohto, Unilever, Taisho, Angfa, LOreal, Kaminomoto, Merck, Yanagiya Honten, Amorepacific, Procter & Gamble, Himalaya, Gerolymatos International, Merz Pharma, Leader Teck, Vasu Healthcare, VLCC, Ales Group, Shanxi Ante, Wansheng Pharmaceutical, Advanced Skin and Hair, Humanwell Healthcare, Topfond, Lifes2good, Bawang, YNK Pharmaceutical, Apollo, Jingxiutang, Rogaine, Marico”. As per the latest research Alopecia (Hair Loss Treatment) market is expected to expand at a CAGR of xx% in the forecast period.

Scope Of The Report

Report Attributes
Report DetailsReport Title

Alopecia (Hair Loss Treatment) Market Research Report

By Type

Shampoos and Conditioners, Medicine Product

By Application

Men, Women

By Companies

Shiseido, Rohto, Unilever, Taisho, Angfa, LOreal, Kaminomoto, Merck, Yanagiya Honten, Amorepacific, Procter & Gamble, Himalaya, Gerolymatos International, Merz Pharma, Leader Teck, Vasu Healthcare, VLCC, Ales Group, Shanxi Ante, Wansheng Pharmaceutical, Advanced Skin and Hair, Humanwell Healthcare, Topfond, Lifes2good, Bawang, YNK Pharmaceutical, Apollo, Jingxiutang, Rogaine, Marico

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2020

Historical Year

2018 to 2019 (Data from 2010 can be provided as per availability)

Forecast Year

Global Alopecia (Hair Loss Treatment) Industry Outlook

Global Alopecia (Hair Loss Treatment) Market Report Segments:

The global Alopecia (Hair Loss Treatment) market is segmented on the basis of:

Types

Shampoos and Conditioners, Medicine Product

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights into the market. Furthermore, it discusses the latest product developments & innovation in the market.

Applications

Men, Women

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and the driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

Shiseido
Rohto
Unilever
Taisho
Angfa
LOreal
Kaminomoto
Merck
Yanagiya Honten
Amorepacific
Procter & Gamble
Himalaya
Gerolymatos International
Merz Pharma
Leader Teck
Vasu Healthcare
VLCC
Ales Group
Shanxi Ante
Wansheng Pharmaceutical
Advanced Skin and Hair
Humanwell Healthcare
Topfond
Lifes2good
Bawang
YNK Pharmaceutical
Apollo
Jingxiutang
Rogaine
Marico

Global Alopecia (Hair Loss Treatment) Market Overview

Highlights of The Alopecia (Hair Loss Treatment) Market Report:

The market structure and projections for the coming years.
Drivers, restraints, opportunities, and current trends of Alpha Hydroxy Acid for Cosmetic Market.
Historical data and forecast.
Estimations for the forecast period 2028.
Developments and trends in the market.
By Type:

Shampoos and Conditioners
Medicine Product

By Application:

Men
Women

Market scenario by region, sub-region, and country.
Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Alopecia (Hair Loss Treatment) Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.

Regional Analysis

North America
Europe
Asia Pacific
Middle East & Africa
Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

Correctly Positioning New Products
Market Entry Strategies
Business Expansion Strategies
Consumer Insights
Understanding Competition Scenario
Product & Brand Management
Channel & Customer Management
Identifying Appropriate Advertising Appeals

Global Alopecia (Hair Loss Treatment) Market Statistics

 

8 Reasons to Buy This Report

Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
Implemented Robust Methodology to Prepare the Report
Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
Provides Information About the Top-winning Strategies Implemented by Industry Players.
In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
Customization of the Report Available

Global Alopecia (Hair Loss Treatment) Market

Source

Recent Posts

CTP-543 for Alopecia Areata

CTP-543 for Alopecia Areata

Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Concert Pharmaceuticals, Inc. (NASDAQ: CNCE) today announced it has initiated THRIVE-AA2, the second planned Phase 3 clinical trial to evaluate the efficacy and safety of CTP-543, an oral Janus kinase inhibitor, in adult patients with moderate to severe alopecia areata. The Company expects to report topline results from THRIVE-AA2 in the second half of 2022. Under current timelines, the Company believes that positive results from two Phase 3 trials could serve as the basis for submitting a New Drug Application to the U.S. Food and Drug Administration (FDA) in early 2023 for CTP-543 for the treatment of moderate to severe alopecia areata in adult patients.

“We expect the CTP-543 THRIVE-AA clinical program to provide the pivotal data needed to support our registration,” said James V. Cassella, Ph.D., Chief Development Officer of Concert Pharmaceuticals. “The continued support of the alopecia areata community has been essential in progressing our program, and the initiation of this second Phase 3 trial brings us another step closer to seeking FDA-approval. We are hopeful that CTP-543 will be one of the first FDA-approved treatments for alopecia areata and will offer an important therapeutic option for this challenging autoimmune disease.”

“Alopecia areata can bring disruption and burden to daily life. But with the progress of clinical trials, there’s hope for patients,” said Thea Chassin, the Founder and Chief Executive Officer of Bald Girls Do Lunch Inc., an alopecia areata advocacy, education and support nonprofit. “We’re grateful for Concert’s research on behalf of the alopecia areata community. We applaud Concert’s goal to develop a potential new medication.”

About the THRIVE-AA2 Study

THRIVE-AA2 (NCT04797650) is a randomized, double-blind, placebo-controlled clinical trial in adult patients with moderate to severe alopecia areata at sites in the U.S., Canada and Europe evaluating the regrowth of scalp hair after 24 weeks of dosing using the Severity of Alopecia Tool (SALT). Key aspects of THRIVE-AA2 include:

  • Patient characteristics: adults age 18-65 years with ≥ 50% hair loss are eligible for the study;
  • Expected enrollment size: approximately 440 patients;
  • Dosing: 8 mg or 12 mg of CTP-543 or placebo twice-daily for 24 weeks; and
  • Primary endpoint: Percent of patients achieving a SALT score ≤ 20 at Week 24.

For more information about the THRIVE-AA1 and THRIVE-AA2 studies, please visit www.clinicaltrials.gov.

About CTP-543 and Alopecia Areata

CTP-543 is an oral selective inhibitor of Janus kinases JAK1 and JAK2. The FDA has granted CTP-543 Breakthrough Therapy designation for the treatment of adult patients with moderate to severe alopecia areata and Fast Track designation for the treatment of alopecia areata.

Alopecia areata is an autoimmune disease in which the immune system attacks hair follicles, resulting in partial or complete loss of hair on the scalp and body. Alopecia areata may affect up to 1 million Americans at any given time1. The scalp is the most commonly affected area, but any hair-bearing site can be affected alone or together with the scalp. The onset of the disease can occur throughout life and affects both women and men. Alopecia areata can be associated with serious psychological consequences, including anxiety and depression. There are currently no drugs approved by the FDA for the treatment of alopecia areata.

The FDA selected alopecia areata as one of eight new disease areas that it focused on under its Patient-Focused Drug Development Initiative (PFDDI) in 2016-2017. The goal of the PFDDI is to bring patient perspectives into an earlier stage of product development. Following the FDA’s Patient-Focused Drug Development meeting held in September 2017 on alopecia areata, the FDA summarized the input shared by patients and patient representatives in a Voice of the Patient report. Additional information on the PFDDI is available online.

About Concert

Concert Pharmaceuticals is a clinical stage biopharmaceutical company that is developing small molecule drugs that it discovered through the application of its DCE Platform® (deuterated chemical entity platform). Selective incorporation of deuterium into known molecules has the potential, on a case-by-case basis, to provide better pharmacokinetic or metabolic properties, thereby enhancing their clinical safety, tolerability or efficacy. Concert’s lead product candidate is in late-stage development for the treatment of alopecia areata, a serious autoimmune dermatological condition. Concert is also assessing a number of earlier-stage pipeline candidates.

Concert Pharmaceuticals Initiates THRIVE-AA2 Phase 3 Clinical Trial Evaluating CTP-543 for Alopecia Areata

Source

Recent Posts

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

Global OTC Hair Loss Treatments Market

The OTC Hair Loss Treatments is expected to grow from USD XX.0 million in 2018 to USD XX.0 million by 2025, at a Compound Annual Growth Rate (CAGR) of XX.0% during the forecast period.

The research provides insights for the global OTC Hair Loss Treatments market based on different Types, End-Users and Regions, and competitive landscape of these segments are analyzed in detail.

A wide range of market influence factors are taken into consideration in the analysis, and potential developing factors for different Types, End-Users and Regions are also included in the report in order to figure out the most promising development trends in the OTC Hair Loss Treatments industry.

For presenting the most potential investment fields in North America, Europe, Asia Pacific and Latin America, Middle East & Africa, the market capacity and consumption potential of more than 34 major powers are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

The Snapshot of Global OTC Hair Loss Treatments Market Segmentations:

By Players:

  • Merck
  • J&J
  • Taisho Pharma
  • Costco Wholesale
  • Wal-Mart
  • Bayer
  • Zhejiang Wansheng Pharma
  • Sichuan Medco Huakang Pharma
  • Zhendong Anter
  • DrFormulas
  • Renata
  • DrRPFLEGER
  • DS Healthcare Group

By Types:

  • Minoxidil
  • Procapil
  • Other

By End-User:

  • Male
  • Female

By Regions:

North America

  • United States
  • Canada
  • Mexico

Europe

  • Germany
  • UK
  • France
  • Italy
  • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)
  • Spain
  • Belgium
  • Poland
  • Russia
  • Turkey
  • Others

Asia-Pacific

  • China
  • Japan
  • India
  • South Korea
  • Australia and New Zealand
  • ASEAN Countries (Indonesia, Thailand, Malaysia, Singapore, Philippines, Vietnam, Others)

Latin America, Middle East & Africa

  • GCC Countries (Saudi Arabia, United Arab Emirates, Qatar, Others)
  • Brazil
  • Nigeria
  • South Africa
  • Argentina
  • Others

Global OTC Hair Loss Treatments Market

Source

Recent Posts

Alopecia Market Size And Forecast

Alopecia Market Size And Forecast

Alopecia Market Size And Forecast

Alopecia Market was valued at USD 2.68 Billion in 2020 and is projected to reach USD 4.89 Billion by 2028, growing at a CAGR of 7.9% from 2021 to 2028.

Changing lifestyle ad rising prevalence of androgenic and areata alopecia across the globe is primary factors for driving growth of Global Alopecia Market. Also, the rise in disposable income of the people and growing awareness regarding alopecia treatment is fueling the growth of Global Alopecia Market. The Global Alopecia Market report provides a holistic evaluation of the market. The report offers comprehensive analysis of key segments, trends, drivers, restraints, competitive landscape, and factors that are playing a substantial role in the market.

Global Alopecia Market Definition

Alopecia areata is also called as spot baldness. It is a medical condition in which hair is lost from some or all areas of the body. Often it results in few bald spots on the scalp of the people. Generally size of spot is of coin. In few cases all the hair on the scalp or the body may lose for permanent.

Alopecia areata can be considered as an autoimmune disorder resulting from a breach in the immune privilege of the hair follicles. Risk factor for alopecia areata includes family history of the same medical condition. The mechanism involves failure by the body to recognize its own cells due to destruction of the hair follicle.

Till now there is no cure for the condition but some medications are tried for regrowth such as cortisone injection, sunscreen to protect the area being affected from cold and sun, glass if incase eyelashes has affected or missing. Another type alopecia andrgenetic which is common in the gender, in men such condition is also recognized as male-pattern baldness.

In this case hair is lost in well-defined manner. After some time hairline foam characteristic ‘M’ which is often progressing to the partial or complete baldness.in case of female it is different condition then male. In women, hair becomes thinner than normal from all over the head and often it further leads to total baldness. Androgenetic alopecia in men’s is resulted from some medical conditions such as coronary heart disease, enlargement of prostate, hypertension and many others.

Global Alopecia Market Overview

Changing lifestyle such as immoderate intake of alcohol and tobacco, and growing stress indices among the people are considered as major factor for rising prevalence of alopecia. Though the epidemiology of the disease is unknown, the genetic factor is considered as a one of the cause and linked to several cases of alopecia. In addition, rise in disposal income of the people and building emphasis on aesthetics are poised to drive the market growth of alopecia product.

Furthermore, aging and anomalies also boosting demand for alopecia treatment. Ender also plays important role in disease susceptibility. As per American Hair Loss Association, around 95% of the hair loss in men is due to androgenic alopecia and awareness among consumers is fueling the growth of Global Alopecia Market.

Moreover, rising prevalence of chronic disorders such as Polycystic Ovary Disease (PCOD), hyperthyroidism, acute stress disorder, hypothyroidism, cancer, lupus, and hypopituitarism are influencing the Global Alopecia Market.

New drug and technologies developments in the field such as emergence of rapid-action JAK inhibitors and hair growth stimulation through PRP treatment and pluripotent stem cells are accelerating the growth of Global Alopecia Market. However, high cost of treatment and lack of awareness in underdeveloped countries are anticipated to restrict the growth of Global Alopecia Market. Nevertheless, launch of new products and technologies are expected to generate new opportunities for the Global Alopecia Market during forecasted period.

Global Alopecia Market Segmentation Analysis

Global Alopecia Market is segmented based on Disease Type, Sales Channel, Gender, End-User, And Geography.

Alopecia Market, By Disease Type

• Alopecia areata
• Androgenetic alopecia
• Others

Based on Disease Type, Alopecia Market is segmented as Alopecia areata, Androgenetic alopecia and others. Alopecia areata sement is expected to hold largest share in the Alopecia Market. The growth is contributed to the high disease prevalence across the globe and increasing consumer awareness regarding treatments. Also, alopecia is most prevalent in the people who are suffering from autoimmune disorders. Androgenetic alopecia segment is expected to grow at fastest pace due to launch of multiple promising pipeline candidates and significant growth in the incidence rate.

Alopecia Market, By Sales Channel

• OTC
• Prescriptions

Based on Sales Channel, Alopecia Market is bifurcated into OTC and Prescriptions. Among these two segments, Prescriptions segment is expected to hold largest share in the alopecia market by sales channels. Various factors that are driving the growth of segments are cost effective treatment, easy accessibility of therapies and increasing number of approvals for medications.

Alopecia Market, By Gender

• Male
• Female

Based on Gender, Alopecia Market is bifurcated into Male and Female. Among these two segments, male segment are dominating the Alopecia Market, By Gender as androgen is leading cause of androgenic alopecia in men also, and increasing geriatric population across the globe and increasing tobacco intake by people are fueling the growth of male segment.

Alopecia Market, By End-User

• Homecare setting
• Dermatology clinics

Based on End-User, Alopecia Market is bifurcated into Homecare setting and Dermatology clinics. Among these two, Dermatology clinics segment is dominating the market. The growth is attributed to the increasing number of hair transplantation, and restoration surgeries. Homecare settings segment is also growing due to broadening penetration of laser treatment and rise in regulatory sanctions of homecare products.

Alopecia Market, By Geography
  • North America
  • Europe
  • Asia Pacific
  • Rest of the world

On the basis of Geography, the Global Alopecia Market is classified into North America, Europe, Asia Pacific, and Rest of the world. North America is expected to hold largest market share due to growing advancement in the technology, novel product development and increasing disposal income of the people in the region is fueling the growth of alopecia market in the region. Asia-Pacific is expected to grow at fastest pace over the next few years. Large population base and growing consumer awareness regarding treatments are expected to boost the growth of alopecia market in the region.

Key Players in Alopecia Market

The “Global Alopecia Market” study report will provide a valuable insight with an emphasis on global market including some of the major players such as Sun Pharmaceutical Industries Ltd., Merck & Co., Inc., Cipla Inc., Johnson and Johnson AG, Lexington International LLC, Transitions Hair Pty Ltd., Cirrus Hair Centers, Vita-Cos-Med Klett-Loch GmbH, Capillus, and Follica, Inc.

Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share and market ranking analysis of the above-mentioned players globally.

Alopecia Market Size And Forecast

Source

Recent Posts

Global Seborrhea Market

Global Seborrhea Market

Global Seborrhea Market

According to Apex Market Research, the Seborrhea market was valued at USD xx.xx million in 2019 and is anticipated to grow at a CAGR of xx% during the forecast period from 2020 to 2028.

The report on Seborrhea Market delivers detailed analysis covering major regional trends, market dynamics, and offer the country-level market value of the Seborrhea industry.

Some of the major aspects considered during the course of research comprise the definition of the product, classification of the product, industry structure, different participants in the Seborrhea ecosystem, etc.

The report comprises market value and forecast for the period from 2020 to 2028, CAGR measured for the individual segment and regional market, competitive landscape of key market players, and profiling of major providers participating in the Seborrhea market.

The following manufacturers are covered in this report:

  • Aclaris Therapeutics Inc
  • Amorepacific Corp
  • Biomar Microbial Technologies
  • EpiPharm AG
  • Vyome Biosciences Pvt Ltd

The report estimates the Seborrhea market economy trend, market numbers (Mn/Bn USD) and CAGR from 2020-2028, considering 2019 as the base year. A global Seborrhea market report consist of all leading industry players, Seborrhea business sections, company profile, revenue supply by Seborrhea industry sections, global Seborrhea market trends, acquisitions and arrangements, contact info, recent development, geographic examination and even more using the assistance.

Since the onset of COVID-19 in December 2019, the governments of various countries declared lockdown and as result, numerous economies around the world experienced severe economic downturn. Since early 2020, the Seborrhea market witnessed the impact of COVID-19 The report objects to provide a pre-COVID-19 state of the Seborrhea market in years 2020 and 2019 and moreover it offers a forecast for the Covid-19 period from 2020 to 2028. The report provides COVID-19 impact on the Seborrhea market, global analysis, different challenges or threats and opportunities for stakeholders involved in the Seborrhea market.

Report Opportunity: Global Seborrhea Market

This report delivers an analytical examination of the Seborrhea market summarized in broad sections such as

  1. Seborrhea Market Summary
  2. Key Commercial Growths in the Seborrhea Industry
  3. Market Dynamics Affecting the Seborrhea Industry
  4. Important Market Trends and Future Development Scenario of the Seborrhea Market
  5. Seborrhea Market Revenue and Forecast, by Type, 2018 – 2028
  6. Competitive Landscape of Seborrhea Industry
  7. Positioning of Main Market Players in the Seborrhea Industry
  8. Seborrhea Market Revenue and Forecast, by Application, 2018 – 2028
  9. Seborrhea Market Revenue and Forecast, by End-use, 2018 – 2028
  10. Seborrhea Market Revenue and Forecast, by Geography, 2018 – 2028

Seborrhea Market Segmentation:

The report provides a detailed examination of the Seborrhea market on the basis of various segments such as type, application and end-use industry. The Seborrhea market is segmented as follows:

Seborrhea Market, by Type:

  • Artemether
  • Hydrogen Peroxide
  • Ketoconazole
  • Others

Seborrhea Market, by Application:

  • Hospital
  • Clinic
  • Others

Geographic Coverage

The report on the Seborrhea market delivers an in-depth country-level cross-sectional analysis across different regions around the globe. The report comprises of complete market value and forecast for the following countries and regions:

North America Seborrhea Market Revenue and Forecast

  • U.S.
  • Canada

Europe Seborrhea Market Revenue and Forecast

  • UK
  • Germany
  • France
  • Rest of Europe

Asia Pacific Seborrhea Market Revenue and Forecast

  • China
  • Japan
  • India
  • Rest of Asia Pacific

Latin America Seborrhea Market Revenue and Forecast

  • Mexico
  • Brazil
  • Rest of Latin America

Middle East and Africa Seborrhea Market Revenue and Forecast

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

Global Seborrhea Market

Source

Recent Posts

Seborrheic Dermatitis Treatment Market

Seborrheic Dermatitis Treatment Market

Seborrheic Dermatitis Treatment Market

Seborrheic Dermatitis is a type of eczema that appears on oil-producing glands like the scalp, nose and upper back. Seborrheic Dermatitis can be caused due to hormonal changes or illness, cold, dry weather, stress, harsh detergents, chemicals and soaps. It is characterized by itchy reddish or pink patches of skin, accompanied by greasy flakes or scales. Seborrheic Dermatitis is a common dermatological disorder in the United States and worldwide.

Seborrheic Dermatitis is more prevalent in immune-compromised patients such as HIV patients, patients with lymphoma and organ transplant recipients.

Dandruff is considered to be a mild form of Seborrheic dermatitis and comparing with Seborrheic Dermatitis, dandruff is much more common, and affects approximately 50% of the general adult population worldwide. According to National Center for Biotechnology Information, In a study in the U.S. and China, dandruff prevalence was 81–95% in African Americans, 66–82% in Caucasians, and 30–42% in Chinese.

In mild cases, a medicated shampoo or a topical antifungal cream or (such as selenium sulfide, ketoconazole,  coal tar) may be enough to control symptoms whereas in severe cases, we may require a prescription for a mild corticosteroid medication to calm the inflammation. Recent improvements in the eczema treatment have increased the quality of life of many patients but still a large affected population of about 66.3 million patients are left untapped.

Seborrheic Dermatitis Treatment Market: Drivers and Restraints

Advancements in Seborrheic Dermatitis products and treatment methods have led to the integration of innovative solutions in Seborrheic Dermatitis Furthermore, rising awareness regarding personal care products, and increasing adoption of e-Commerce marketing techniques by manufacturers of Seborrheic Dermatitis products is expected to create a favourable environment for the growth of the Seborrheic Dermatitis market over the forecast period.  better patient-physician relationships leading to increasing demand for treatments pertaining to face and skin related problems is also propelled the growth of the Seborrheic Dermatitis Treatment market.  However, stringent regulations for product approvals and generic competition are the factors that can hinder the market growth of Seborrheic Dermatitis Treatment globally.

Seborrheic Dermatitis Treatment Market: Segmentation

Treatment

  • Antifungal products
  • Corticosteroid lotions
  • Prescription-strength medicated shampoos
  • Sulfur products

Route of Administration

  • Oral
  • Topical

Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Market Research Methodology – Perfected through Years of Diligence

A key factor for our unrivalled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.

Seborrheic Dermatitis Treatment Market: Overview

Based upon the most recent evidence, the aetiology of dandruff and Seborrheic dermatitis appears to be dependent upon three factors: microfloral metabolism, sebaceous gland secretions, and individual susceptibility. Traditionally, non-scalp seborrheic dermatitis has been treated with either topical or oral steroids. However, renewed interest in the role of Malassezia yeasts and the known side effects of topical steroids have made antifungal medications an increasingly popular choice which in turn expected to have a meteoric growth of the Seborrheic Dermatitis Treatment market over a forecast period.

Seborrheic Dermatitis Treatment Market: Region-wise Outlook

A geographic condition regarding for Seborrheic Dermatitis Treatment market has been segmented into five broad regions: North America, Latin America, Europe, Asia-Pacific including Japan, and the Middle East & Africa. North America leads the market for Seborrheic Dermatitis Treatment reasons being lifestyle changes, new product innovations, and early treatment adoption. Europe is the second leading market for Seborrheic Dermatitis Treatment due to development activities and a large research base. The Asia Pacific market is also expected to grow at a higher rate owing to changing lifestyle, a large target patient pool, rapid population growth, adoption of western lifestyle, and growth in research and development. These factor are likely to drive the market growth of the Seborrheic Dermatitis Treatment market during the forecast period globally.

Seborrheic Dermatitis Treatment Market: Key Market Participants

Some of the major key players of Seborrheic Dermatitis Treatment market constitute Sonoma Pharmaceuticals, Inc., Merck & Co., Inc., West-Ward Pharmaceuticals Corp.,
Allen & Hanburys A Glaxo Canada Ltd. Co., Valeant Pharmaceuticals North America

The report covers an exhaustive analysis on

  • Market Segments
  • Market Dynamics
  • Historical Actual Market Size, 2012 – 2014
  • Market Size & Forecast 2015 to 2024
  • Supply & Demand Value Chain
  • Market Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
  • Aircraft Refurbishing Market Drivers and Restraints

Regional analysis for the Market includes

  • North America
  • Latin America
  • Europe
  • Asia Pacific & Japan
  • The Middle East and Africa

Report Highlights:

  • Shifting Industry dynamics
  • In-depth market segmentation
  • Historical, current and projected industry size Recent industry trends
  • Key Competition landscape
  • Strategies of key players and product offerings
  • Potential and niche segments/regions exhibiting promising growth
  • A neutral perspective towards market performance

Seborrheic Dermatitis Treatment Market

Source

Recent Posts

Hair Loss Treatment Industry Market

2020-2025 Global Hair Loss Treatment Market

2020-2025 Global Hair Loss Treatment Market Report

Hair loss refers to the phenomenon of hair loss. The hair that is normally shed is the hair that is in the period of retreat and rest. Since the hair entering the degenerative period and the newly entering the growing period is constantly in dynamic balance, the normal amount of hair can be maintained.

This report elaborates the market size, market characteristics, and market growth of the Hair Loss Treatment industry, and breaks down according to the type, application, and consumption area of Hair Loss Treatment. The report also conducted a PESTEL analysis of the industry to study the main influencing factors and entry barriers of the industry.

In Chapter 3.4 of the report, the impact of the COVID-19 outbreak on the industry was fully assessed. Fully risk assessment and industry recommendations were made for Hair Loss Treatment in a special period. This chapter also compares the markets of Pre COVID-19 and Post COVID-19.

In addition, chapters 8-12 consider the impact of COVID-19 on the regional economy.

Key players in the global Hair Loss Treatment market covered in Chapter 13:

Teva Pharmaceutical Industries Ltd.
Merck & Co., Inc.
Shiseido Co., Ltd.
Johnson & Johnson, Inc.
Dr. Reddy’s Laboratories Ltd.
The Himalaya Drug Company
Taisho Pharmaceutical Holdings Co., Ltd
Zhangguang 101 Science & Technology Co., Ltd.
Cipla Ltd.
Johnson & Johnson, Inc.
Cellmid Ltd.

In Chapter 6, on the basis of types, the Hair Loss Treatment market from 2015 to 2025 is primarily split into:

Topical Drugs
Oral Drugs
Injectable Drugs
Hair Transplant Services
Low-level Laser Therapy

In Chapter 7, on the basis of applications, the Hair Loss Treatment market from 2015 to 2025 covers:

Hospitals
Dermatologic and Trichology Clinics
Home Care Settings
Aesthetic Clinics

Geographically, the detailed analysis of production, trade of the following countries is covered in Chapter 4.2, 5:

United States

Europe

China

Japan

India

Geographically, the detailed analysis of consumption, revenue, market share and growth rate of the following regions are covered in Chapter 8, 9, 10, 11, 12:

North America (Covered in Chapter 8)

United States

Canada

Mexico

Europe (Covered in Chapter 9)

Germany

UK

France

Italy

Spain

Others

Asia-Pacific (Covered in Chapter 10)

China

Japan

India

South Korea

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 11)

Saudi Arabia

UAE

South Africa

Others

South America (Covered in Chapter 12)

Brazil

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

2020-2025 Global Hair Loss Treatment Market Report

Source

Recent Posts

Stem Cell Alopecia Treatment Market

Global Platelet Rich Plasma

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Report 2021

The research report includes specific segments by region (country), by company, by Type, and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027.

Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type

Androgenic Alopecia
Congenital Alopecia
Cicatricial Or Scarring Alopecia

Segment by Application

Hospital
Dermatology Clinic
Other

By Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company

Kerastem
Eclipse
Regen Lab SA
Stemcell Technologies
RepliCel Life Sciences
Histogen
Glofinn Oy.

Global Platelet Rich Plasma and Stem Cell Alopecia Treatment Market Research Report 2021

Source

Recent Posts

Global Alopecia Treatment Market

Alopecia Treatment Market

Global Alopecia Treatment Market Research Report 2021-2027

The research team projects that the Alopecia Treatment market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027.

The prime objective of this alopecia report is to help the user understand the market in terms of its definition, segmentation, market potential, influential trends, and the challenges that the market is facing with 10 major regions and 50 major countries.

Deep researches and analysis were done during the preparation of the report. The readers will find this report very helpful in understanding the market in depth. The data and the information regarding the market are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the industry experts.

The facts and data are represented in the report using diagrams, graphs, pie charts, and other pictorial representations. This enhances the visual representation and also helps in understanding the facts much better.

By Market Players:

Teva Pharmaceutical Industries

Merck

Johnson&Johnson

Reddy`s Laboratories

Cipla

Cellmid

Himalaya Drug

Taisho Pharmaceutical Holdings

By Type

Topical Drugs

Oral Drugs

Injectable

Hair Transplant Services

Other

By Application

Hospitals

Dermatology And Trichology Clinics

Home Care Settings

Other

By Regions/Countries:

North America

United States

Canada

Mexico

East Asia

China

Japan

South Korea

Europe

Germany

United Kingdom

France

Italy

Russia

Spain

Netherlands

Switzerland

Poland

South Asia

India

Pakistan

Bangladesh

South East Asia

Indonesia

Thailand

Singapore

Malaysia

Philippines

Vietnam

Myanmar

Middle East

Turkey

Saudi Arabia

Iran

United Arab Emirates

Israel

Iraq

Qatar

Kuwait

Oman

Africa

Nigeria

South Africa

Egypt

Algeria

Morocoo

Oceania

Australia

New Zealand

South America

Brazil

Argentina

Colombia

Chile

Venezuela

Peru

Puerto Rico

Ecuador

Rest of the World

Kazakhstan

Points Covered in The Report

The points that are discussed within the report are the major market players that are involved in the market such as market players, raw material suppliers, equipment suppliers, end users, traders, distributors and etc.

The complete profile of the companies is mentioned. And the capacity, production, price, revenue, cost, gross, gross margin, sales volume, sales revenue, consumption, growth rate, import, export, supply, future strategies, and the technological developments that they are making are also included within the report. This report analyzed 12 years of data history and forecast.

The growth factors of the market is discussed in detail wherein the different end users of the market are explained in detail.

Data and information by market player, by region, By Type, By Application and etc, and custom research can be added according to specific requirements.

The report contains the SWOT analysis of the market. Finally, the report contains the conclusion part where the opinions of the industrial experts are included.

Key Reasons to Purchase

To gain insightful analyses of the market and have a comprehensive understanding of the global market and its commercial landscape.

Assess the production processes, major issues, and solutions to mitigate the development risk.

To understand the most affecting driving and restraining forces in the market and its impact in the global market.

Learn about the market strategies that are being adopted by leading respective organizations.

To understand the future outlook and prospects for the market.

Besides the standard structure reports, we also provide custom research according to specific requirements.

The report focuses on Global, Top 10 Regions and Top 50 Countries Market Size of Alopecia Treatment 2016-2021, and development forecast 2022-2027 including industries, major players/suppliers worldwide and market share by regions, with company and product introduction, position in the market including their market status and development trend By Types and applications which will provide its price and profit status, and marketing status & market growth drivers and challenges, with base year as 2020.

Key Indicators Analysed

Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2021 & Sales by Product Types.

Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2022-2027. Further, the report provides break down details about each region & countries covered in the report. Identifying its production, consumption, import & export, sales volume & revenue forecast.

Market Analysis by Product Type: The report covers the majority of Product Types in the Alopecia Treatment Industry, including its product specifications by each key player, volume, sales by Volume and Value (M USD).

Market Analysis By Application Type: Based on the Alopecia Treatment Industry and its applications, the market is further sub-segmented into several major Application of its industry. It provides you with the market size, CAGR & forecast by each industry applications.

Market Trends: Market key trends include Increased Competition and Continuous Innovations.

Opportunities and Drivers: Identifying the Growing Demands and New Technology

Porters Five Force Analysis: The report will provide the state of competition in the industry depends on five basic forces: the threat of new entrants, bargaining power of suppliers, bargaining power of buyers, the threat of substitute products or services, and existing industry rivalry.

Global Alopecia Treatment Market Research Report 2021-2027

Source

Recent Posts